Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Visit the company website

Bullboard - Investor Discussion Forum SQI Diagnostics Inc. V.SQD

Alternate Symbol(s):  SQIDF

SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision medicine tests that run on SQI's automated systems. Our tests simplify and improve COVID19 antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada and Europe. More than half of its revenues come from the United States.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Markets across the globe see red
Canada’s main stock index was down by triple digits come Wednesday’s close, amid losses in the energy, base metal, and technology sectors. Telecom and industrials moved higher. ... read article.
@ the Bell: Caps on Russian oil not enough for the TSX
Following a new round of restrictions announced at a meeting of G7 leaders capping prices on the sale and purchase of Russian oil, Canada’s commodity-heavy main stock index came out of the gate... read article.
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TORONTO, June 20, 2022 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health article.

New Press Release - SQI Diagnostics Inc. Announces Closing of $4.05 Million Debt Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ TORONTO, June 17, 2022 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and article.

RE:RE:RE:padres^[Ss] flip forward to page 11  rate and reply

RE:RE:padres more

RE:The truth is somewhere in the middle...

Apologies wrong board   rate and reply

The truth is somewhere in the middle...

between Stocktree's (and now Hmmm's ) call of $ 0 and JCI's call of $ 10B (for one small component). Either way, there is money to be made.  Never look at the SP as a proxy more


I didn't see any evidence of SQI at BIO2022 but there seems to be much coverage around Accelerated Approval Pathways as well as major league partnerships.... You might want to check out the more

There is so much more, but listen...

5:40 to 6:50 mark is the most relevant to SQI and UHN & Dr. Shaf Keshavjee.   3D-printed organs: The future of transplantation - › 2022/06/10 › health › 3d-printed-organs...  rate and reply


is there more to see than a padres game?  rate and reply

Don't want to get CV-19, then make sure you have Antibodies

If you're still waiting for herd immunity for COVID-19, it's time to ... › Health › story  rate and reply

Another group where CV19 Antibody tests are important...


RE:Morris continued - Be a leader and be trustworthy

It's time for a public campaign from the highly accomplished SQI Board of Directors.   They have massive public influence and a combined wealth in the billions to back it up. more

Morris continued - Organ savings

SQI builds for these practitioners by anticipating and meeting the needs of those who bear these excellent qualities. That’s what we’re doing with our EXACT Antibody Test and with our RALI-Dx or more

Morris continued - Be a leader and be trustworthy

I think it’s hard for people in the general population to know who to trust and what message to trust. The biggest contribution we can make is to provide trustworthy information. Be an example as more

RALI-Dx importance....(Andrew Morris shares)

Data can help the system focus its efforts on those who are truly going to become sick. This was part of the drive to develop our RALI-Dx test for COVID, which is meant to triage patients in more

June Investor deck suggests EXACT test "to launch in days"

June 10 Investor Deck suggests.... EXACT COVID19 Antibody TEST CLIA-Approved in US Q1-22 – to launch in days  Below is from PatientPop piece - May 15th.   Are more

Andrew Morris & team poised to make difference in many lives


COVID-19 cases are on the rise. Does it matter? YES

Some experts are pushing back on the deemphasis of case numbers, saying they still matter.     “The bunk that cases are not important is preposterous,” Eric more

Expect spread....

BA.5: Latest omicron variant expected to spread fast18 hours ago  rate and reply

RE:RE:Precision Medicine - SQI is a key partner of UHN

SQI now has a CCO, so presumably monitization is commencing...stay tuned...perhaps there will be some communication...    Tim McGough Chief Commercial OfficerChief more
The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >

Visit the company website


General information/Investor Relations:


Customer support:

Local: 416-674-9500
Toll free: 1-888-829-0849